BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9401688)

  • 1. Infection of bone marrow macrophages by equine infectious anemia virus.
    Swardson CJ; Lichtenstein DL; Wang S; Montelaro RC; Kociba GJ
    Am J Vet Res; 1997 Dec; 58(12):1402-7. PubMed ID: 9401688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of virulent and avirulent equine infectious anemia virus on macrophage cytokine expression.
    Lim WS; Payne SL; Edwards JF; Kim I; Ball JM
    Virology; 2005 Feb; 332(1):295-306. PubMed ID: 15661161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages.
    Steagall WK; Robek MD; Perry ST; Fuller FJ; Payne SL
    Virology; 1995 Jul; 210(2):302-13. PubMed ID: 7542416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
    Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
    Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine infectious anemia virus-infected dendritic cells retain antigen presentation capability.
    Rivera JA; McGuire TC
    Virology; 2005 May; 335(2):145-54. PubMed ID: 15840514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages.
    Lin YZ; Cao XZ; Li L; Li L; Jiang CG; Wang XF; Ma J; Zhou JH
    Virus Res; 2011 Sep; 160(1-2):274-82. PubMed ID: 21782860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of equine infectious anemia virus on hematopoietic progenitors in vitro.
    Swardson CJ; Kociba GJ; Perryman LE
    Am J Vet Res; 1992 Jul; 53(7):1176-9. PubMed ID: 1323227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglobulinemia and lymphocyte subset changes in naturally infected, inapparent carriers of equine infectious anemia virus.
    Russell KE; Walker KM; Miller RT; Sellon DC
    Am J Vet Res; 1998 Aug; 59(8):1009-15. PubMed ID: 9706205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
    McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
    Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
    Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
    Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
    Tschetter JR; Byrne KM; Perryman LE; McGuire TC
    Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of equine infectious anemia lentivirus disease.
    McGuire TC; O'Rourke KI; Perryman LE
    Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
    Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
    Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
    Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
    Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoencephalitis associated with selective viral replication in the brain of a pony with experimental chronic equine infectious anemia virus infection.
    Oaks JL; Long MT; Baszler TV
    Vet Pathol; 2004 Sep; 41(5):527-32. PubMed ID: 15347829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
    Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
    Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic inclusions in cells infected with the virus of equine infectious anemia (EIAV).
    Weiland F; Matheka HD
    Eur J Cell Biol; 1984 Mar; 33(2):294-9. PubMed ID: 6325195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol ester stimulation of equine macrophage cultures alters expression of equine infectious anemia virus.
    Sellon DC; Walker KM; Russell KE; Perry ST; Fuller FJ
    Vet Microbiol; 1996 Oct; 52(3-4):209-21. PubMed ID: 8972047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin treatment of equine infectious anaemia virus-infected horse macrophage cultures decreases production of infectious virus.
    Smith TA; Davis E; Carpenter S
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():747-55. PubMed ID: 9568970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.